More News on the Windsor Framework for Medicines Supply in Northern Ireland
More Korean MFSD publishes Revision 7 of Comparative Dissolution Test Guideline
More USP <88> "Biological Reactivity Tests, In Vivo" is currently also undergoing Revision
More Appearance as a Release Test? This is not the Way to get through an Inspection
More Clean-up Phase and Recovery Time - is there a Difference?
More Updates to the EMA Q&A Documents on Centralised Procedures
More MRA: EU-US Agreement to recognise GMP Inspections for Veterinary Medicines
More MHRA announces Cooperation with seven international Partners
More GMP Inspection finds weak points in the GMP training system: How to (not) react
More EMA issues Reflection Paper on Demonstrating Efficacy for Advanced Therapies
More FDA Publishes Final Q&A Paper on Risk-Based Monitoring of Clinical Trials
More Good Machine Learning Practice: FDA issues Discussion Paper on AI/ML in Drug Development
More FDA Recommendations to reduce HIV Transmission through Blood and Blood Products
More Publication of the 21st Edition of the EDQM Blood Guide
More FDA Form 483 due to Insufficient Investigations after OOS and OOT Results
More Consequences of manufacturing non-pharmaceutical Products on pharmaceutical Equipment